Global Blood Therapeutics Inc
(NASDAQ : GBT)

( )
GBT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.86%122.371.1%$687.52m
GILDGilead Sciences, Inc.
-1.28%80.170.9%$652.57m
AMGNAmgen Inc.
-1.33%180.531.1%$453.70m
BIIBBiogen Inc.
-2.83%328.551.2%$418.30m
REGNRegeneron Pharmaceuticals, Inc.
-0.05%432.762.7%$322.07m
VRTXVertex Pharmaceuticals Incorporated
-2.31%151.061.9%$219.47m
INCYIncyte Corporation
-0.62%113.482.5%$198.97m
ALXNAlexion Pharmaceuticals, Inc.
-2.75%135.201.9%$188.62m
ILMNIllumina, Inc.
0.80%211.553.5%$133.98m
ALNYAlnylam Pharmaceuticals, Inc
0.76%115.5710.7%$131.21m
EXELExelixis, Inc.
-0.70%26.986.5%$126.80m
BLUEBluebird Bio, Inc.
-1.54%140.3517.3%$119.91m
SRPTSarepta Therapeutics, Inc.
-0.91%51.4716.9%$110.18m
BMRNBioMarin Pharmaceutical Inc.
-1.47%86.464.4%$109.02m
CLVSClovis Oncology, Inc.
-2.49%75.5716.5%$96.52m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.